We are live on
!
Find out more
Viatris
VTRS
VTRS
Fund managers haven’t disclosed any holdings of VTRS yet.
VTRS Hedge Fund Activity: Q1 2026 in Review
1,019 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q1 2026, worth a combined $13.4B — up 9.9% from $12.2B a quarter earlier.
Buyers outnumbered sellers: 134 funds opened new VTRS positions and 94 closed out — a net gain of 40 holders — while 349 added to existing stakes and 317 trimmed.
The largest buyer was Qube Research & Technologies (QRT), adding an estimated $128M. The largest seller was T. Rowe Price Associates, cutting an estimated $185M.
- 1,019 institutional investors held Viatris (VTRS) as of Q1 2026, up from 1,005 in Q4 2025.
- Funds reported $13.4B of Viatris stock for Q1 2026, up 9.9% quarter-over-quarter.
- 134 funds opened new Viatris positions in Q1 2026 and 94 closed out, a net change of +40 holders.
- The largest Viatris buyer in Q1 2026 was Qube Research & Technologies (QRT), an estimated $128M added.
- The largest Viatris seller in Q1 2026 was T. Rowe Price Associates, an estimated $185M sold.
Based on aggregated 13F filings for Q1 2026.